This study, carried out in a large cohort of treated essential hypertensives attending an out-patient hospital hypertension clinic, extends previous observations by showing that a clustering of two or three markers of organ damage (OD) has a higher prevalence than a single organ involvement. These findings call for a systematic evaluation of cardiac and extracardiac OD in treated hypertensive patients referred to a specialist setting.
A few studies have reported that hypertensiverelated damage in one organ may be associated with similar alterations in other organs. 1, 2 Furthermore, systematic data on the prevalence of different markers of organ damage (OD) and more importantly on their cluster in the hypertensive population are rather scanty.
We investigated the cluster of signs of cardiac, vascular and renal damage in a large sample of treated hypertensives to provide new and wider evidence on the value of a systematic search for OD during antihypertensive treatment. A total of 2213 treated essential hypertensives included in the Evaluation of Target Organ Damage in Hypertension (ETODH) were considered for this analysis. 3 The main exclusion criteria included a history or evidence of congestive heart failure, atrial fibrillation, previous stroke, significant cardiac valve disease, previous myocardial infarction or coronary bypass, secondary causes of hypertension and neoplastic disease.
All patients underwent extensive laboratory and ultrasound investigations searching for microalbuminuria (MA) and/or increased serum creatinine, left ventricular hypertrophy (LVH) or LV concentric remodelling, carotid plaques and/or intima-media thickening.
Organ damage was defined by the presence of MA (urinary albumin excretion: 20-300 mg/24 h) or proteinuria (4300 mg/24 h), an increase in serum creatinine (X1.3 mg/dl in men and X1.2 mg/dl in women; renal OD), ultrasonographic evidence of LVH, LV concentric remodelling (cardiac OD) and vascular alterations. In particular, LVH was defined as an LV mass index equal to or higher than 51 g m À2.7 in men and 47 g m À2.7 in women. 4 A plaque was defined as a focal thickening greater than 1.3 mm in any segment of carotid arteries, and diffuse intima-media thickening was diagnosed when the average common carotid wall thickness exceeded 0.8 mm (vascular OD). 5 Technical details of cardiac and carotid ultrasonographic examinations have been reported previously. 6 Of the 2213 hypertensive subjects examined, 1122 were males (50.7%). The mean age was 55.7±10.7 years (range: 17-90 years). The mean clinic systolic blood pressure (BP) and diastolic BP were 147 ± 19 and 91±10 mm Hg, respectively; BP values were X140/90 mm Hg in 79.1% of the study sample; the prevalence of metabolic syndrome, according to ATP III modified criteria, 7 , was 42.5; 21.5% of the subjects were smokers and 6.2% had type 2 diabetes mellitus.
The prevalence rates of the patients categorized according to the absence (group I) or the presence of one marker (group II), two (group III) or three (group IV) markers of OD were 17.2, 36.4, 33.9 and 12.5%, respectively. Age, body mass index, clinic systolic BP/diastolic BP, duration of hypertension, fasting blood glucose, total cholesterol, LDL cholesterol, triglycerides, serum creatinine, prevalence of metabolic syndrome, type 2 diabetes, smoking and antihypertensive association therapy all showed a progressive increase from group I to group IV; HDL cholesterol and prevalence of clinic BP, in contrast, showed the opposite trend.
In the whole population, the most common phenotype of OD was LVH (46.5%) followed by carotid plaque (44.1%), carotid intima-media (IM) thickening (28.8%), MA (19.1%), LV concentric remodelling (10.4%) and increased serum creatinine (3.1%) (Figure 1a) .
Among the patients with OD, these phenotypes were present as a unique sign of organ involvement according to the following MA 23.6%, (100 out of 422), carotid thickening 31.0% (198 out of 638), LVH 33.4% (345 out of 1030), LVCR 42.3% (97 out of 229) and carotid plaque 51.2% (500 out of 976; Figure 1b) .
Our study provides several new findings. First, it shows that subclinical organ alterations with established prognostic significance, such as those addressed in the present analysis, are present in approximately 80% of the study sample. Second, the coexistence of two or three markers of OD is prevailing over single organ involvement: up to 46% of the patients, indeed, exhibited involvement of more than one organ as compared to 36% with a single organ involvement. More importantly, any marker of OD was present as a unique sign of cardiovascular (CV) involvement in a limited fraction of the patients, ranging from 23.6% for MA to 51.2% for carotid plaques. This allows us to conclude that all markers of damage should be routinely searched for in treated hypertensives, as damage in one organ is frequently associated with alterations in another one. Third, an inverse relationship was found between clinic BP control and the number of organs damaged; the prevalence of controlled BP, indeed, was 30% in patients without OD, 15% in those with multiple involvement and intermediate in those with one or two damages.
In the whole population, LVH was the most common phenotype of OD followed in ranking order by carotid plaques, carotid thickening, MA, LV concentric remodelling and increased serum creatinine. This finding suggests that ultrasonographic abnormalities in LV structure are sensitive markers of OD in treated subjects within a broad range of ages, duration and grade of hypertension, probably because they reflect the integrated impact of haemodynamic and non-haemodynamic stimuli on the heart. 8 This study also shows a clear relationship between two cardinal manifestations of OD, namely altered patterns of LV geometry and carotid atherosclerosis; in fact, in patients positive for two markers of preclinical organ involvement, the prevalence rates of LVH or LV concentric remodelling and carotid atherosclerosis were 88.8 and 89.2%, respectively, whereas early renal damage was present in 21.7% of cases. This confirms previous findings that alterations in cardiac structure induced by hypertension tend to be paralleled by alterations in the arterial wall structure. 1, 9 In contrast, the prevalence of renal OD, mostly represented by MA, was much less frequent than carotid atherosclerosis or altered LV patterns. A notable implication of our study should be pointed out. Approximately 66% of our patients with OD showed a high-risk phenotype characterized by the simultaneous involvement of two or three organs. All physicians should be aware of this detrimental association and accurately search for other signs of OD if one marker is found to be positive; this may be particularly true in patients with MA, as this phenotype was an isolated sign of OD in only 23% of the cases.
A stepwise decrease in the proportion of BP control (that is, BP o140/90 mm Hg) occurred from patients without OD,to patients with one, two and three markers of preclinical organ involvement. This point indicates that uncontrolled clinic BP in chronically treated hypertensives is often associated with subclinical damage in one or more organs.
Our observations also expand the available evidence on the clinical profile of patients with multiple OD. [10] [11] [12] In this study, patients with multiple OD (that is, LVH, carotid atherosclerosis and MA) were older, more frequently males, and had higher systolic BP, longer duration of hypertension, greater prevalence of type 2 diabetes, metabolic syndrome and smoking. This underlines the synergic role of several modifiable and non-modifiable risk factors in the development of cardiac and extra-cardiac OD. Finally, some limits of this study deserve to be mentioned. In particular, our data pertain to a relatively small sample size of hypertensive individuals referred to a single specialist centre. It is possible that in patients referring to the care of general practitioner who represent the hypertensive population as a whole, the prevalence rates of single and multiple OD are substantially lower. What is known about this topic K A growing body of evidence underlines the relevance of organ damage (OD) as a determinant of CV morbidity and mortality. Quantitative markers of OD (that is, increased left ventricular mass, carotid intima-media thickening, reduced glomerular filtration rate and urinary albumin excretion) have been shown to be associated with an increased incidence of CV events. K A few studies have reported that hypertensive-related damage in one organ may be associated with similar alterations in other organs.
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What this study adds
K
The present study, carried out in treated essential hypertensives referred to a specialist centre, shows that a clustering of two or three markers of OD is prevailing over a single organ involvement. K These findings call for a systematic evaluation of cardiac and extracardiac OD in treated hypertensive patients referred to a specialist setting.
